Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Minority Interest (2018 - 2021)

Historic Minority Interest for Amphastar Pharmaceuticals (AMPH) over the last 4 years, with Q2 2021 value amounting to $45.2 million.

  • Amphastar Pharmaceuticals' Minority Interest rose 105.91% to $45.2 million in Q2 2021 from the same period last year, while for Jun 2021 it was $45.2 million, marking a year-over-year increase of 105.91%. This contributed to the annual value of $46.4 million for FY2020, which is 55.24% up from last year.
  • Amphastar Pharmaceuticals' Minority Interest amounted to $45.2 million in Q2 2021, which was up 105.91% from $45.4 million recorded in Q1 2021.
  • Over the past 5 years, Amphastar Pharmaceuticals' Minority Interest peaked at $46.4 million during Q4 2020, and registered a low of $21.9 million during Q3 2018.
  • Over the past 4 years, Amphastar Pharmaceuticals' median Minority Interest value was $45.3 million (recorded in 2019), while the average stood at $42.3 million.
  • Per our database at Business Quant, Amphastar Pharmaceuticals' Minority Interest soared by 10247.09% in 2019 and then tumbled by 99.65% in 2021.
  • Amphastar Pharmaceuticals' Minority Interest (Quarter) stood at $31.9 million in 2018, then soared by 44.6% to $46.2 million in 2019, then grew by 0.55% to $46.4 million in 2020, then fell by 2.56% to $45.2 million in 2021.
  • Its last three reported values are $45.2 million in Q2 2021, $45.4 million for Q1 2021, and $46.4 million during Q4 2020.